ArrowMark Colorado Holdings LLC Makes New $6.12 Million Investment in Teleflex Incorporated $TFX

ArrowMark Colorado Holdings LLC bought a new stake in Teleflex Incorporated (NYSE:TFX) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 50,000 shares of the medical technology company’s stock, valued at approximately $6,118,000. ArrowMark Colorado Holdings LLC owned about 0.11% of Teleflex as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also made changes to their positions in the company. Abrams Bison Investments LLC purchased a new stake in shares of Teleflex in the 3rd quarter worth about $112,317,000. Alliancebernstein L.P. increased its holdings in Teleflex by 92.3% during the 3rd quarter. Alliancebernstein L.P. now owns 64,162 shares of the medical technology company’s stock valued at $7,851,000 after acquiring an additional 30,795 shares in the last quarter. Creative Planning raised its position in Teleflex by 329.1% during the third quarter. Creative Planning now owns 44,362 shares of the medical technology company’s stock worth $5,428,000 after acquiring an additional 34,024 shares during the last quarter. Lazard Asset Management LLC raised its position in Teleflex by 142.7% during the third quarter. Lazard Asset Management LLC now owns 68,351 shares of the medical technology company’s stock worth $8,363,000 after acquiring an additional 40,183 shares during the last quarter. Finally, AQR Capital Management LLC lifted its holdings in shares of Teleflex by 478.1% in the third quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock valued at $287,603,000 after purchasing an additional 1,956,811 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Stock Performance

NYSE TFX opened at $107.29 on Monday. The business’s 50-day moving average price is $109.80 and its 200 day moving average price is $117.96. The company has a current ratio of 2.54, a quick ratio of 2.01 and a debt-to-equity ratio of 0.81. Teleflex Incorporated has a twelve month low of $100.18 and a twelve month high of $143.32. The company has a market capitalization of $4.74 billion, a PE ratio of -5.22, a price-to-earnings-growth ratio of 0.67 and a beta of 0.87.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, February 26th. The medical technology company reported $1.93 EPS for the quarter, missing the consensus estimate of $3.73 by ($1.80). Teleflex had a negative net margin of 30.56% and a positive return on equity of 14.30%. The business had revenue of $569.00 million during the quarter, compared to analysts’ expectations of $912.57 million. During the same quarter last year, the firm earned $3.89 EPS. The firm’s quarterly revenue was down 28.5% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Friday, March 6th will be issued a $0.34 dividend. The ex-dividend date is Friday, March 6th. This represents a $1.36 dividend on an annualized basis and a yield of 1.3%. Teleflex’s dividend payout ratio (DPR) is presently -6.62%.

Analysts Set New Price Targets

Several analysts have issued reports on the stock. Wells Fargo & Company upped their price target on shares of Teleflex from $116.00 to $130.00 and gave the company an “equal weight” rating in a report on Friday, February 27th. Zacks Research downgraded Teleflex from a “hold” rating to a “strong sell” rating in a research report on Monday, March 2nd. Wall Street Zen lowered Teleflex from a “hold” rating to a “sell” rating in a research note on Saturday, March 7th. Truist Financial increased their target price on Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a report on Thursday, December 18th. Finally, Needham & Company LLC raised their price target on Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a research report on Thursday, February 26th. Two investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $140.83.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.